245 related articles for article (PubMed ID: 9225830)
1. Partial preservation of pancreatic beta-cells by vanadium: evidence for long-term amelioration of diabetes.
Cam MC; Li WM; McNeill JH
Metabolism; 1997 Jul; 46(7):769-78. PubMed ID: 9225830
[TBL] [Abstract][Full Text] [Related]
2. Distinct glucose lowering and beta cell protective effects of vanadium and food restriction in streptozotocin-diabetes.
Cam MC; Rodrigues B; McNeill JH
Eur J Endocrinol; 1999 Nov; 141(5):546-54. PubMed ID: 10576774
[TBL] [Abstract][Full Text] [Related]
3. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
Pederson RA; Ramanadham S; Buchan AM; McNeill JH
Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Assessment of Proliferative Effects of Oral Vanadium on Pancreatic Islet Volumes and Beta Cell Numbers of Diabetic Rats.
Pirmoradi L; Noorafshan A; Safaee A; Dehghani GA
Iran Biomed J; 2016; 20(1):18-25. PubMed ID: 26459400
[TBL] [Abstract][Full Text] [Related]
6. Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
Cam MC; Pederson RA; Brownsey RW; McNeill JH
Diabetologia; 1993 Mar; 36(3):218-24. PubMed ID: 8462769
[TBL] [Abstract][Full Text] [Related]
7. Trophic effects of vanadium on beta-cells of STZ-induced insulin dependent diabetic rats & evidence for long-term relief of diabetes mellitus.
Dehghani GA; Sotoodeh M; Omrani GR
Indian J Med Res; 1999 Aug; 110():70-5. PubMed ID: 10573657
[TBL] [Abstract][Full Text] [Related]
8. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
9. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas.
Coskun O; Ocakci A; Bayraktaroglu T; Kanter M
Tohoku J Exp Med; 2004 Jul; 203(3):145-54. PubMed ID: 15240923
[TBL] [Abstract][Full Text] [Related]
10. Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment.
Ramanadham S; Brownsey RW; Cros GH; Mongold JJ; McNeill JH
Metabolism; 1989 Oct; 38(10):1022-8. PubMed ID: 2677609
[TBL] [Abstract][Full Text] [Related]
11. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
Adewole SO; Ojewole JA
Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
13. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
14. Concentration-dependent glucose-lowering effects of oral vanadyl are maintained following treatment withdrawal in streptozotocin-diabetic rats.
Cam MC; Faun J; McNeill JH
Metabolism; 1995 Mar; 44(3):332-9. PubMed ID: 7885278
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
[TBL] [Abstract][Full Text] [Related]
16. Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: persistence of insulin secreting capacities assessed by isolated pancreas studies.
Poucheret P; Gross R; Cadène A; Mantéguetti M; Serrano JJ; Ribes G; Cros G
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):197-204. PubMed ID: 8927039
[TBL] [Abstract][Full Text] [Related]
17. A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis.
Cho JM; Jang HW; Cheon H; Jeong YT; Kim DH; Lim YM; Choi SH; Yang EK; Shin CY; Son MH; Kim SH; Kim HJ; Lee MS
Diabetes Res Clin Pract; 2011 Jan; 91(1):72-9. PubMed ID: 21093089
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
19. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats.
Kanter M; Coskun O; Korkmaz A; Oter S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Jul; 279(1):685-91. PubMed ID: 15224410
[TBL] [Abstract][Full Text] [Related]
20. Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on hyperglycemia in streptozotocin-induced diabetic rats.
Hirotani Y; Ikeda T; Yamamoto K; Kurokawa N
Biol Pharm Bull; 2007 May; 30(5):1015-20. PubMed ID: 17473455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
